T. Rowe Price Associates’s PMV Pharmaceuticals PMVP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,600
| Closed | -$37K | – | 3128 |
|
|
2025
Q1 | $37K | Hold |
33,600
| – | – | ﹤0.01% | 2959 |
|
|
2024
Q4 | $51K | Hold |
33,600
| – | – | ﹤0.01% | 2931 |
|
|
2024
Q3 | $51K | Hold |
33,600
| – | – | ﹤0.01% | 2925 |
|
|
2024
Q2 | $55K | Sell |
33,600
-9,202
| -21% | -$15.1K | ﹤0.01% | 2843 |
|
|
2024
Q1 | $73K | Buy |
42,802
+17,858
| +72% | +$30.5K | ﹤0.01% | 2828 |
|
|
2023
Q4 | $78K | Hold |
24,944
| – | – | ﹤0.01% | 2746 |
|
|
2023
Q3 | $154K | Buy |
24,944
+983
| +4% | +$6.07K | ﹤0.01% | 2568 |
|
|
2023
Q2 | $150K | Buy |
23,961
+344
| +1% | +$2.15K | ﹤0.01% | 2602 |
|
|
2023
Q1 | $113K | Buy |
23,617
+5,278
| +29% | +$25.3K | ﹤0.01% | 2658 |
|
|
2022
Q4 | $160K | Buy |
18,339
+475
| +3% | +$4.14K | ﹤0.01% | 2596 |
|
|
2022
Q3 | $213K | Buy |
17,864
+2,251
| +14% | +$26.8K | ﹤0.01% | 2519 |
|
|
2022
Q2 | $222K | Buy |
15,613
+1,109
| +8% | +$15.8K | ﹤0.01% | 2554 |
|
|
2022
Q1 | $302K | Sell |
14,504
-36,720
| -72% | -$765K | ﹤0.01% | 2538 |
|
|
2021
Q4 | $1.18M | Sell |
51,224
-100,554
| -66% | -$2.32M | ﹤0.01% | 1941 |
|
|
2021
Q3 | $4.52M | Buy |
+151,778
| New | +$4.52M | ﹤0.01% | 1524 |
|
|
2021
Q2 | – | Sell |
-119,375
| Closed | -$3.93M | – | 2942 |
|
|
2021
Q1 | $3.93M | Buy |
+119,375
| New | +$3.93M | ﹤0.01% | 1521 |
|